| Released | Contributor | Author | Title | Pages | Price |
| 29-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Cambrex Corporation has a current Overall Rating of A (Highest Rating). | 7 |
$25 |
| 28-Nov-2009 | Stock Traders Daily | Thomas H. Kee Jr. | Trading Report for (CBM). A detailed Technical Analysis + Trading Plans for Day Trading, Swing Trading, and Long Term proactive investments in (CBM). | 5 |
$18 |
| 28-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Drug Intelligence Monitor: overall outlook NEUTRAL - 25 new Leaders; 25 new Laggards. | 65 |
$20 |
| 28-Nov-2009 | PriceTarget Research, Inc. |
N/A
| S&P Small Cap Intelligence Monitor: overall outlook NEUTRAL - 25 new Leaders; 25 new Laggards. | 65 |
$40 |
| 28-Nov-2009 | Standard & Poor's STARS Report |
N/A
| Cambrex Corp | 8 |
$35 |
| 27-Nov-2009 | Pechala's Reports | Lubomir Pechala | CAMBREX CORP (CBM=US) 2-weeks forecast | 1 |
$10 |
| 27-Nov-2009 | Pechala's Reports | Frantisek Pechala | CAMBREX CORP (CBM=US) 12-months forecast | 1 |
$15 |
| 26-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for BIOTECHNOLOGY | 18 |
$49 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: CAMBREX -- CBM | 1 |
$4 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: CCC , CBM , IPHS , NL , PPO , KWR -- CHEMICALS | 3 |
$4 |
1.48% Nasdaq 
0.06 (1.06%) 
Research Reports
